Fátima Camões

Fátima Camões

Auto-generated profile, based on publicly available information

Fátima Camões

Centre for Cell Biology/Institute of Biomedicine & Department of Biology, University of Aveiro, Aveiro 3810-193, Portugal

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
JCJoseph L. Costello
Joseph L. Costello
ICInês Castro
Inês Castro
FCFátima Camões
Fátima Camões
TSTina A. Schrader
Tina A. Schrader
DMDoug McNeall
Doug McNeall
MSMichael Schrader
Michael Schrader
Tail-anchored (TA) proteins contain a single transmembrane domain (TMD) at the C-terminus that anchors them to the membranes of organelles where they mediate critical cellular processes. Accordingly, mutations in genes encoding TA proteins have been identified in a number of severe inherited disorders. Despite the importance of correctly targeting a TA protein to its appropriate membrane, the mechanisms and signals involved are not fully understood. In this study, we identify additional peroxisomal TA proteins, discover more proteins that are present on multiple organelles, and reveal that a combination of TMD hydrophobicity and tail charge determines targeting to distinct organelle locations in mammals. Specifically, an increase in tail charge can override a hydrophobic TMD signal and re-direct a protein from the ER to peroxisomes or mitochondria and vice versa. We show that subtle changes in those parameters can shift TA proteins between organelles, explaining why peroxisomes and mitochondria have many of the same TA proteins. This enabled us to associate characteristic physicochemical parameters in TA proteins with particular organelle groups. Using this classification allowed successful prediction of the location of uncharacterized TA proteins for the first time.

1 January 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
FCFátima Camões
Fátima Camões
MIMarkus Islinger
Markus Islinger
SGSofia C. Guimaraes
Sofia C. Guimaraes
SKSreedhar Kilaru
Sreedhar Kilaru
MSMartin Schuster
Martin Schuster
MSMichael Schrader
Michael Schrader

12 December 2008 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
FCF. Camões
F. Camões
NBN. A. Bonekamp
N. A. Bonekamp
HDH. K. Delille
H. K. Delille
MSM. Schrader
M. Schrader

10 February 2016 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
AFAna Rita Ferreira
Ana Rita Ferreira
AMAna Cristina Magalhaes
Ana Cristina Magalhaes
FCFátima Camões
Fátima Camões
AGAna Gouveia
Ana Gouveia
MVMarta Vieira
Marta Vieira
DRDaniela Ribeiro
Daniela Ribeiro
Hepatitis C virus (HCV) is the cause of one of the most prevalent viral infections worldwide. Upon infection, the HCV genome activates the RIG‐I‐MAVS signalling pathway leading to the production of direct antiviral effectors which prevent important steps in viral propagation.MAVS localizes at peroxisomes and mitochondria and coordinate the activation of an effective antiviral response: peroxisomal MAVS is responsible for a rapid but short‐termed antiviral response, while the mitochondrial MAVS is associated with the activation of a stable response with delayed kinetics.The HCV NS3‐4A protease was shown to specifically cleave the mitochondrial MAVS, inhibiting the downstream response.In this study, we have analysed whether HCV NS3‐4A is also able to cleave the peroxisomal MAVS and whether this would have any effect on the cellular antiviral response. We show that NS3‐4A is indeed able to specifically cleave this protein and release it into the cytosol, a mechanism that seems to occur at a similar kinetic rate as the cleavage of the mitochondrial MAVS. Under these conditions, RIG‐I‐like receptor (RLR) signalling from peroxisomes is blocked and antiviral gene expression is inhibited. Our results also show that NS3‐4A is able to localize at peroxisomes in the absence of MAVS. However, mutation studies have shown that this localization pattern is preferred in the presence of a fully cleavable MAVS. These findings present evidence of a viral evasion strategy that disrupts RLR signalling on peroxisomes and provide an excellent example of how a single viral evasion strategy can block innate immune signalling from different organelles.

1 May 2004 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
FAFátima Camões Amador
Fátima Camões Amador
AHAna Gabriela Henriques
Ana Gabriela Henriques
Odete A. B. Da Cruz E SilvaOdete A. B. Da Cruz E Silva
Odete A. B. Da Cruz E Silva
ESEdgar F da Cruz e Silva
Edgar F da Cruz e Silva

1 May 2001 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
FAFátima C. Amador
Fátima C. Amador
MSMaria S. Santos
Maria S. Santos
COCatarina R. Oliveira
Catarina R. Oliveira